During tumorigenesis, the hypoxic microenvironment and/or genetic alteration pVHL may cause a high level of HIF-1α in cancer cells [7], [8], suggesting that HIF-1α is a potential target in tumor therapy. The gene discussed is VHL; the disease is neoplasm.